The global Automation in Biopharmaceutical market was valued at 106.7 Million USD in 2020 and will grow with a CAGR of 6.12% from 2020 to 2027, based on newly published report.

The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

The global biopharmaceutical industry is the most rapidly growing industry in the science and technology sector owing to increasing R&D investments in biopharmaceutical drug development facilities. The global automation market in biopharmaceutical industry includes deployment of automation in biopharmaceutical academic research centers, manufacturing and research companies, clinical labs, and government approved labs.One trend in the market is continuous manufacturing. Advantages of continuous operations are well-recognized in various industries. It completes the process in a shorter time as it omits the hold steps, reduces shut down time, and reduces the labor requirement. Over the decades, upstream processing utilized this technology.” According to the report, one driver in the market is use of automation in data acquisition. Traditionally, research labs collect data manually and store it in spreadsheets. This method is not only time-consuming but also affects operational efficiency and is prone to errors. It also restricts monitoring of data in real time. The biopharmaceutical industry is working on data collection and adding the information from spreadsheets to a database. Database collection of upstream and downstream processes is being utilized to create a library that increases operational efficiency and process optimization. Further, the report states that one challenge in the market is high R&D cost. The biopharmaceutical industry is a rapidly growing industry in pharmaceuticals. Complex drugs are manufactured with the help of 3-D modeling and are produced with high efficacy and precision. These drugs can provide medication to medical issues that were once incurable. Currently, the biopharmaceutical industry is looking to yield new products to address diseases such as cancer, Alzheimer`s disease, and hepatitis C. Innovations in the biopharmaceutical industry are highly expensive. The average cost associated with a new drug is around $2 billion, including the cost of unsuccessful drug approvals, out of which almost $400 million is the cost included in pre-clinical and clinical testing.

By Market Verdors:

Danaher

GE

PerkinElmer

Tecan Trading

Thermo Fisher Scientific

Bruker

Peak Analysis & Automation

Waters

Capsugel

RheoSense

Eirechrom

BioProcess International

Novasep

By Types:

Clinical stage automation

Drug discovery stage automation

By Applications:

Research and Development

Clinical

Key Indicators Analysed

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.

Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.

Market Trends: Market key trends which include Increased Competition and Continuous Innovations.

Opportunities and Drivers: Identifying the Growing Demands and New Technology

Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Key Reasons to Purchase

To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements.

Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2022-2027)

1.4.2 East Asia Market States and Outlook (2022-2027)

1.4.3 Europe Market States and Outlook (2022-2027)

1.4.4 South Asia Market States and Outlook (2022-2027)

1.4.5 Southeast Asia Market States and Outlook (2022-2027)

1.4.6 Middle East Market States and Outlook (2022-2027)

1.4.7 Africa Market States and Outlook (2022-2027)

1.4.8 Oceania Market States and Outlook (2022-2027)

1.4.9 South America Market States and Outlook (2022-2027)

1.5 Global Automation in Biopharmaceutical Market Size Analysis from 2022 to 2027

1.5.1 Global Automation in Biopharmaceutical Market Size Analysis from 2022 to 2027 by Consumption Volume

1.5.2 Global Automation in Biopharmaceutical Market Size Analysis from 2022 to 2027 by Value

1.5.3 Global Automation in Biopharmaceutical Price Trends Analysis from 2022 to 2027

1.6 COVID-19 Outbreak: Automation in Biopharmaceutical Industry Impact

Chapter 2 Global Automation in Biopharmaceutical Competition by Types, Applications, and Top Regions and Countries

2.1 Global Automation in Biopharmaceutical (Volume and Value) by Type

2.1.1 Global Automation in Biopharmaceutical Consumption and Market Share by Type (2016-2021)

2.1.2 Global Automation in Biopharmaceutical Revenue and Market Share by Type (2016-2021)

2.2 Global Automation in Biopharmaceutical (Volume and Value) by Application

2.2.1 Global Automation in Biopharmaceutical Consumption and Market Share by Application (2016-2021)

2.2.2 Global Automation in Biopharmaceutical Revenue and Market Share by Application (2016-2021)

2.3 Global Automation in Biopharmaceutical (Volume and Value) by Regions

2.3.1 Global Automation in Biopharmaceutical Consumption and Market Share by Regions (2016-2021)

2.3.2 Global Automation in Biopharmaceutical Revenue and Market Share by Regions (2016-2021)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2016-2021 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2016-2021 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global Automation in Biopharmaceutical Sales, Consumption, Export, Import by Regions (2016-2021)

4.1 Global Automation in Biopharmaceutical Consumption by Regions (2016-2021)

4.2 North America Automation in Biopharmaceutical Sales, Consumption, Export, Import (2016-2021)

4.3 East Asia Automation in Biopharmaceutical Sales, Consumption, Export, Import (2016-2021)

4.4 Europe Automation in Biopharmaceutical Sales, Consumption, Export, Import (2016-2021)

4.5 South Asia Automation in Biopharmaceutical Sales, Consumption, Export, Import (2016-2021)

4.6 Southeast Asia Automation in Biopharmaceutical Sales, Consumption, Export, Import (2016-2021)

4.7 Middle East Automation in Biopharmaceutical Sales, Consumption, Export, Import (2016-2021)

4.8 Africa Automation in Biopharmaceutical Sales, Consumption, Export, Import (2016-2021)

4.9 Oceania Automation in Biopharmaceutical Sales, Consumption, Export, Import (2016-2021)

4.10 South America Automation in Biopharmaceutical Sales, Consumption, Export, Import (2016-2021)

Chapter 5 North America Automation in Biopharmaceutical Market Analysis

5.1 North America Automation in Biopharmaceutical Consumption and Value Analysis

5.1.1 North America Automation in Biopharmaceutical Market Under COVID-19

5.2 North America Automation in Biopharmaceutical Consumption Volume by Types

5.3 North America Automation in Biopharmaceutical Consumption Structure by Application

5.4 North America Automation in Biopharmaceutical Consumption by Top Countries

5.4.1 United States Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

5.4.2 Canada Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

5.4.3 Mexico Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

Chapter 6 East Asia Automation in Biopharmaceutical Market Analysis

6.1 East Asia Automation in Biopharmaceutical Consumption and Value Analysis

6.1.1 East Asia Automation in Biopharmaceutical Market Under COVID-19

6.2 East Asia Automation in Biopharmaceutical Consumption Volume by Types

6.3 East Asia Automation in Biopharmaceutical Consumption Structure by Application

6.4 East Asia Automation in Biopharmaceutical Consumption by Top Countries

6.4.1 China Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

6.4.2 Japan Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

6.4.3 South Korea Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

Chapter 7 Europe Automation in Biopharmaceutical Market Analysis

7.1 Europe Automation in Biopharmaceutical Consumption and Value Analysis

7.1.1 Europe Automation in Biopharmaceutical Market Under COVID-19

7.2 Europe Automation in Biopharmaceutical Consumption Volume by Types

7.3 Europe Automation in Biopharmaceutical Consumption Structure by Application

7.4 Europe Automation in Biopharmaceutical Consumption by Top Countries

7.4.1 Germany Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

7.4.2 UK Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

7.4.3 France Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

7.4.4 Italy Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

7.4.5 Russia Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

7.4.6 Spain Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

7.4.7 Netherlands Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

7.4.8 Switzerland Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

7.4.9 Poland Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

Chapter 8 South Asia Automation in Biopharmaceutical Market Analysis

8.1 South Asia Automation in Biopharmaceutical Consumption and Value Analysis

8.1.1 South Asia Automation in Biopharmaceutical Market Under COVID-19

8.2 South Asia Automation in Biopharmaceutical Consumption Volume by Types

8.3 South Asia Automation in Biopharmaceutical Consumption Structure by Application

8.4 South Asia Automation in Biopharmaceutical Consumption by Top Countries

8.4.1 India Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

8.4.2 Pakistan Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

8.4.3 Bangladesh Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

Chapter 9 Southeast Asia Automation in Biopharmaceutical Market Analysis

9.1 Southeast Asia Automation in Biopharmaceutical Consumption and Value Analysis

9.1.1 Southeast Asia Automation in Biopharmaceutical Market Under COVID-19

9.2 Southeast Asia Automation in Biopharmaceutical Consumption Volume by Types

9.3 Southeast Asia Automation in Biopharmaceutical Consumption Structure by Application

9.4 Southeast Asia Automation in Biopharmaceutical Consumption by Top Countries

9.4.1 Indonesia Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

9.4.2 Thailand Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

9.4.3 Singapore Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

9.4.4 Malaysia Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

9.4.5 Philippines Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

9.4.6 Vietnam Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

9.4.7 Myanmar Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

Chapter 10 Middle East Automation in Biopharmaceutical Market Analysis

10.1 Middle East Automation in Biopharmaceutical Consumption and Value Analysis

10.1.1 Middle East Automation in Biopharmaceutical Market Under COVID-19

10.2 Middle East Automation in Biopharmaceutical Consumption Volume by Types

10.3 Middle East Automation in Biopharmaceutical Consumption Structure by Application

10.4 Middle East Automation in Biopharmaceutical Consumption by Top Countries

10.4.1 Turkey Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

10.4.2 Saudi Arabia Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

10.4.3 Iran Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

10.4.4 United Arab Emirates Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

10.4.5 Israel Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

10.4.6 Iraq Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

10.4.7 Qatar Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

10.4.8 Kuwait Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

10.4.9 Oman Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

Chapter 11 Africa Automation in Biopharmaceutical Market Analysis

11.1 Africa Automation in Biopharmaceutical Consumption and Value Analysis

11.1.1 Africa Automation in Biopharmaceutical Market Under COVID-19

11.2 Africa Automation in Biopharmaceutical Consumption Volume by Types

11.3 Africa Automation in Biopharmaceutical Consumption Structure by Application

11.4 Africa Automation in Biopharmaceutical Consumption by Top Countries

11.4.1 Nigeria Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

11.4.2 South Africa Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

11.4.3 Egypt Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

11.4.4 Algeria Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

11.4.5 Morocco Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

Chapter 12 Oceania Automation in Biopharmaceutical Market Analysis

12.1 Oceania Automation in Biopharmaceutical Consumption and Value Analysis

12.2 Oceania Automation in Biopharmaceutical Consumption Volume by Types

12.3 Oceania Automation in Biopharmaceutical Consumption Structure by Application

12.4 Oceania Automation in Biopharmaceutical Consumption by Top Countries

12.4.1 Australia Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

12.4.2 New Zealand Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

Chapter 13 South America Automation in Biopharmaceutical Market Analysis

13.1 South America Automation in Biopharmaceutical Consumption and Value Analysis

13.1.1 South America Automation in Biopharmaceutical Market Under COVID-19

13.2 South America Automation in Biopharmaceutical Consumption Volume by Types

13.3 South America Automation in Biopharmaceutical Consumption Structure by Application

13.4 South America Automation in Biopharmaceutical Consumption Volume by Major Countries

13.4.1 Brazil Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

13.4.2 Argentina Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

13.4.3 Columbia Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

13.4.4 Chile Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

13.4.5 Venezuela Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

13.4.6 Peru Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

13.4.7 Puerto Rico Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

13.4.8 Ecuador Automation in Biopharmaceutical Consumption Volume from 2016 to 2021

Chapter 14 Company Profiles and Key Figures in Automation in Biopharmaceutical Business

14.1 Danaher

14.1.1 Danaher Company Profile

14.1.2 Danaher Automation in Biopharmaceutical Product Specification

14.1.3 Danaher Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.2 GE

14.2.1 GE Company Profile

14.2.2 GE Automation in Biopharmaceutical Product Specification

14.2.3 GE Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.3 PerkinElmer

14.3.1 PerkinElmer Company Profile

14.3.2 PerkinElmer Automation in Biopharmaceutical Product Specification

14.3.3 PerkinElmer Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.4 Tecan Trading

14.4.1 Tecan Trading Company Profile

14.4.2 Tecan Trading Automation in Biopharmaceutical Product Specification

14.4.3 Tecan Trading Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.5 Thermo Fisher Scientific

14.5.1 Thermo Fisher Scientific Company Profile

14.5.2 Thermo Fisher Scientific Automation in Biopharmaceutical Product Specification

14.5.3 Thermo Fisher Scientific Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.6 Bruker

14.6.1 Bruker Company Profile

14.6.2 Bruker Automation in Biopharmaceutical Product Specification

14.6.3 Bruker Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.7 Peak Analysis & Automation

14.7.1 Peak Analysis & Automation Company Profile

14.7.2 Peak Analysis & Automation Automation in Biopharmaceutical Product Specification

14.7.3 Peak Analysis & Automation Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.8 Waters

14.8.1 Waters Company Profile

14.8.2 Waters Automation in Biopharmaceutical Product Specification

14.8.3 Waters Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.9 Capsugel

14.9.1 Capsugel Company Profile

14.9.2 Capsugel Automation in Biopharmaceutical Product Specification

14.9.3 Capsugel Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.10 RheoSense

14.10.1 RheoSense Company Profile

14.10.2 RheoSense Automation in Biopharmaceutical Product Specification

14.10.3 RheoSense Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.11 Eirechrom

14.11.1 Eirechrom Company Profile

14.11.2 Eirechrom Automation in Biopharmaceutical Product Specification

14.11.3 Eirechrom Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.12 BioProcess International

14.12.1 BioProcess International Company Profile

14.12.2 BioProcess International Automation in Biopharmaceutical Product Specification

14.12.3 BioProcess International Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.13 Novasep

14.13.1 Novasep Company Profile

14.13.2 Novasep Automation in Biopharmaceutical Product Specification

14.13.3 Novasep Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Chapter 15 Global Automation in Biopharmaceutical Market Forecast (2022-2027)

15.1 Global Automation in Biopharmaceutical Consumption Volume, Revenue and Price Forecast (2022-2027)

15.1.1 Global Automation in Biopharmaceutical Consumption Volume and Growth Rate Forecast (2022-2027)

15.1.2 Global Automation in Biopharmaceutical Value and Growth Rate Forecast (2022-2027)

15.2 Global Automation in Biopharmaceutical Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)

15.2.1 Global Automation in Biopharmaceutical Consumption Volume and Growth Rate Forecast by Regions (2022-2027)

15.2.2 Global Automation in Biopharmaceutical Value and Growth Rate Forecast by Regions (2022-2027)

15.2.3 North America Automation in Biopharmaceutical Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.4 East Asia Automation in Biopharmaceutical Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.5 Europe Automation in Biopharmaceutical Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.6 South Asia Automation in Biopharmaceutical Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.7 Southeast Asia Automation in Biopharmaceutical Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.8 Middle East Automation in Biopharmaceutical Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.9 Africa Automation in Biopharmaceutical Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.10 Oceania Automation in Biopharmaceutical Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.11 South America Automation in Biopharmaceutical Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.3 Global Automation in Biopharmaceutical Consumption Volume, Revenue and Price Forecast by Type (2022-2027)

15.3.1 Global Automation in Biopharmaceutical Consumption Forecast by Type (2022-2027)

15.3.2 Global Automation in Biopharmaceutical Revenue Forecast by Type (2022-2027)

15.3.3 Global Automation in Biopharmaceutical Price Forecast by Type (2022-2027)

15.4 Global Automation in Biopharmaceutical Consumption Volume Forecast by Application (2022-2027)

15.5 Automation in Biopharmaceutical Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology